ScoreWhy is Heron Therapeutics, Inc. ?
1
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -68.60%, its profits have risen by 93.8%
2
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -68.60% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Heron Therapeutics, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Heron Therapeutics, Inc.
-66.4%
-1.23
63.98%
S&P 500
16.12%
0.77
19.29%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.51%
EBIT Growth (5y)
14.98%
EBIT to Interest (avg)
-77.04
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-4.45
Sales to Capital Employed (avg)
0.97
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
11.36
EV to EBIT
121.18
EV to EBITDA
57.04
EV to Capital Employed
2.55
EV to Sales
1.64
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.10%
ROE (Latest)
-11.68%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
NET PROFIT(9M)
Higher at USD -5.4 MM
-13What is not working for the Company
INVENTORY TURNOVER RATIO(HY)
Lowest at 0.7 times
CASH AND EQV(HY)
Lowest at USD 96.12 MM
DEBT-EQUITY RATIO
(HY)
Highest at 570.75 %
PRE-TAX PROFIT(Q)
Lowest at USD -5.86 MM
NET PROFIT(Q)
Lowest at USD -5.86 MM
EPS(Q)
Lowest at USD -0.1
Here's what is not working for Heron Therapeutics, Inc.
Pre-Tax Profit
At USD -5.86 MM has Fallen at -3,104.38%
over average net sales of the previous four periods of USD -0.18 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -5.86 MM has Fallen at -3,104.38%
over average net sales of the previous four periods of USD -0.18 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Inventory Turnover Ratio
Lowest at 0.7 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Pre-Tax Profit
Lowest at USD -5.86 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -5.86 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
EPS
Lowest at USD -0.1
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
Cash and Eqv
Lowest at USD 96.12 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at 570.75 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
